Date:07-May-2024  Time: 1:23 AM
 
 
        
Marksans Pharma Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales241.36204.67182.04153.05
Other Income1.3315.9332.624.30
Total Income242.69220.60214.66157.35
Total Expenditure 199.39167.37155.28130.34
Operating Profit43.3053.2359.3827.01
Interest0.270.230.260.66
Gross Profit43.0353.0059.1226.35
Depreciation8.438.504.723.51
Tax9.7611.687.515.46
Deferred Tax-0.441.542.69-0.42
Reported Profit After Tax25.2931.2944.1917.81
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com